If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGoodwin Regulatory News (GDWN)

Share Price Information for Goodwin (GDWN)

Share Price is delayed by 15 minutes
Get Live Data
17,640.00    360.00 (2.08%)
Bid:
17,440.00
Ask:
17,540.00
Spread: 100.00 (0.573%)
Market Cap: £1.35b
GDWN Live PriceLast checked at - London Stock Exchange

Intraday Goodwin Share Chart

March 2025 Trading Update

19 Mar 2025 08:00

RNS Number : 2754B
Goodwin PLC
19 March 2025
 

GOODWIN PLC

MARCH 2025 TRADING UPDATE

 

We are pleased to report that as of the end of February, the Group's forward order book has reached a new record of £300 million. This milestone reflects the strength of our long-term established contracts and the robustness of our business activities. As a result, we remain on track to deliver second-half profits comparable to those of the first half of the year.

 

One of the recent contributors to this success has been Noreva, our specialised nozzle check valve company based in Germany. Noreva has secured the largest order in its history-a $15 million contract to supply valves for an LNG project. This contract, to be fulfilled over the next two years, positions us well to benefit from the expected release of further LNG projects, in light of the growing global demand for LNG. 

 

The vertical integration within our Group continues to provide a substantial competitive advantage. A significant proportion of the castings for Noreva's major order will be sourced from Goodwin Steel Castings (GSC), our own foundry. Even though we are now casting at a rate of 10 Self Shielded Boxes (SSBs) per month for the nuclear decommissioning market, as well as continuing to cast components for the military contracts that GSC has won, all with multi-year delivery profiles and high likelihood of repeat orders, the foundry still has capacity to take on additional contracts. This puts us in an excellent position to continue to contribute to national strategic defence procurements in both the UK and USA.

 

Looking ahead, the Mechanical Division is poised for further success. While the majority of orders received this year will start to deliver financial returns in the next fiscal year, we are confident that this momentum will continue to build. Our significant investment over the past decade has equipped the Mechanical Division with the necessary facilities, size, and capability to handle increasing workloads across all areas. Our investment into the Goodwin Engineering Training Centre has also supported this growth by successfully operating for over 13 years and training over 300 apprentices to date. It is these individuals who now form part of the Group's highly skilled workforce that is required to sustain our expansion.

 

Meanwhile, our Refractory Division continues to grow and perform well. The investment casting markets, particularly in the jewellery sectors are expanding at an impressive rate, exceeding 10% growth in certain regions. As a global market leader, we are benefiting directly from this trend, with our powder companies in China, India and Thailand achieving record in-month results compared to previous years.

 

Capital expenditure across the Group has decreased significantly as expected. The primary ongoing project, which is non customer funded, is the construction of a new 1,200 m² building at Noreva. Over the next few months, once the equipment has been delivered and installed, this facility will house a CNC press operation converting Duvelco polyimide resin powder into precision pressed parts. With the reduced capital expenditure and our improved profitability, we have successfully reduced Group net debt by a further £10 million since the half-year mark.

 

Finally, with respect to dividend payments, we re-confirm that the second and final instalment of 66.5p per share for the year ending 30th April 2024, approved at our last Annual General Meeting on 2nd October 2024, will be paid on 11th April 2025 to shareholders registered on 21st March 2025.

 

The Board is delighted with the Group's performance and the strategic positioning we have achieved. With our record order book, expanding capabilities, and strong financial foundation, we are well-placed to sustain our success and drive further growth in profitability.

 

T.J.W. Goodwin

Chairman

 

END LEI: 213800N4T1NMSJ57B322

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGRGDXLXBDGUC
Date   Source Headline
14th Aug 20194:36 pmRNSPrice Monitoring Extension
9th Aug 20192:51 pmRNSResults Update
15th Jul 20194:35 pmRNSPrice Monitoring Extension
5th Jul 20194:35 pmRNSPrice Monitoring Extension
1st Jul 20194:41 pmRNSSecond Price Monitoring Extn
1st Jul 20194:36 pmRNSPrice Monitoring Extension
26th Jun 201912:07 pmRNSSecond Price Monitoring Extn
26th Jun 201912:02 pmRNSPrice Monitoring Extension
12th Jun 20192:00 pmRNSChange of Adviser
11th Jun 20194:35 pmRNSPrice Monitoring Extension
10th Jun 20194:35 pmRNSPrice Monitoring Extension
3rd May 20198:42 amRNSDirector/PDMR Shareholding
1st May 201910:03 amRNSDirectorate Change
8th Apr 20191:28 pmRNSDirector/PDMR Shareholding
8th Apr 201912:08 pmRNSSecond Price Monitoring Extn
8th Apr 201912:02 pmRNSPrice Monitoring Extension
2nd Apr 20199:27 amRNSProduct Innovation
2nd Jan 20199:15 amRNSCompany Secretary Change
18th Dec 201810:18 amRNSHalf-year Report
8th Oct 201812:22 pmRNSDirector/PDMR Shareholding
4th Oct 20187:00 amRNSResult of AGM
13th Aug 20183:25 pmRNSPosting of Annual Report and Accounts
26th Jul 20188:10 amRNSPreliminary Results
8th Mar 20184:40 pmRNSSecond Price Monitoring Extn
8th Mar 20184:35 pmRNSPrice Monitoring Extension
6th Mar 20184:35 pmRNSPrice Monitoring Extension
18th Dec 201711:00 amRNSHalf-year Report
25th Oct 20177:00 amRNSDirector/PDMR Shareholding
13th Oct 20173:32 pmRNSDirector/PDMR Shareholding
4th Oct 20173:30 pmRNSResult of AGM
13th Sep 20171:00 pmRNSQuarterly Interim Management Statements
31st Aug 201710:49 amRNSAnnual Financial Report
22nd Aug 20173:32 pmRNSPreliminary Results
3rd Jul 20174:35 pmRNSPrice Monitoring Extension
13th Mar 20174:40 pmRNSSecond Price Monitoring Extn
13th Mar 20174:35 pmRNSPrice Monitoring Extension
10th Mar 20172:15 pmRNSInterim Management Statement
16th Dec 201612:28 pmRNSHalf-year Report
10th Oct 20164:35 pmRNSPrice Monitoring Extension
10th Oct 20161:56 pmRNSDirector/PDMR Shareholding
5th Oct 20163:06 pmRNSResult of AGM and LTIP awards
16th Sep 20164:35 pmRNSPrice Monitoring Extension
14th Sep 20162:40 pmRNSInterim Management Statement
12th Aug 20164:52 pmRNSAnnual Financial Report
29th Jul 20167:00 amRNSPreliminary Results
13th May 20164:35 pmRNSPrice Monitoring Extension
13th May 201610:08 amRNSDirector/PDMR Shareholding
17th Mar 201610:00 amRNSInterim Management Statement
10th Mar 20163:32 pmRNSHome Member State
10th Feb 20164:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.